Imcyse développe des immunothérapies actives et spécifiques visant à traiter et guérir des maladies chroniques sévères causées par des distorsions du système immunitaire.
Location: Belgium, Liège
Employees: 11-50
Total raised: $39.33M
Founded date: 2010
Investors 4
| Date | Name | Website |
| - | Le Groupe ... | sriw.be |
| - | SFPIM | sfpim.be |
| - | KU Leuven ... | lrd.kuleuv... |
| - | Life Scien... | lspvc.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 18.06.2019 | Series B | $39.33M | - |
Mentions in press and media 9
| Date | Title | Description | Source |
| 03.11.2021 | Imcyse Appoints Gene Mack, MBA as Chief Financial Officer | LIÉGE, Belgium, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Imcyse, a clinical-stage biopharmaceutical company... | globenewsw... |
| 03.11.2021 | Imcyse Appoints Gene Mack, MBA as Chief Financial Officer | DGAP-News: Imcyse SA / Key word(s): Personnel Imcyse Appoints Gene Mack, MBA as Chief Financial Off... | marketscre... |
| 03.11.2021 | Imcyse Appoints Gene Mack, MBA as Chief Financial Officer | LIÉGE, Belgium, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Imcyse, a clinical-stage biopharmaceutical company... | marketscre... |
| 24.06.2021 | PRESS RELEASE: Imcyse appoints new Scientific Advisory Board... | DGAP-News: Imcyse SA / Key word(s): Miscellaneous Imcyse appoints new Scientific Advisory Board and ... | marketscre... |
| 24.06.2021 | PRESS RELEASE : Imcyse appoints new Scientific Advisory Boar... | DGAP-News: Imcyse SA / Key word(s): Miscellaneous Imcyse appoints new Scientific Advisory Board and ... | marketscre... |
| 24.06.2021 | Imcyse : appoints new Scientific Advisory Board and opens ne... | DGAP-News: Imcyse SA / Key word(s): Miscellaneous Imcyse appoints new Scientific Advisory Board and... | marketscre... |
| 06.12.2019 | Best of 2019: 10 Belgium tech startups that scored maximum f... | Entrepreneurs in Belgium eyeing to raise funds might have an easier time right now to grow their ric... | siliconcan... |
| 19.06.2019 | Belgium-based biotech startup Imcyse secures €35M Series B f... | Imcyse, a developer of active specific immunotherapies for the treatment and prevention of severe ch... | siliconcan... |
| 18.06.2019 | Imcyse Raises €35M in Series B Funding Round and Grants | Imcyse, a Liège, Belgium-based developer of active specific immunotherapies for the treatment and pr... | finsmes.co... |